ID21338A - Metoda untuk menghasilkan kekebalan aktif dengan vaksin gabungan - Google Patents

Metoda untuk menghasilkan kekebalan aktif dengan vaksin gabungan

Info

Publication number
ID21338A
ID21338A IDW990061A ID990061A ID21338A ID 21338 A ID21338 A ID 21338A ID W990061 A IDW990061 A ID W990061A ID 990061 A ID990061 A ID 990061A ID 21338 A ID21338 A ID 21338A
Authority
ID
Indonesia
Prior art keywords
protozoa
live bacteria
produce active
active immune
subject
Prior art date
Application number
IDW990061A
Other languages
English (en)
Inventor
John A Thoma
Eid E Haddad
Craig E Whitfill
Alan P Avakian
Original Assignee
Embrex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Embrex Inc filed Critical Embrex Inc
Publication of ID21338A publication Critical patent/ID21338A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IDW990061A 1996-09-30 1997-09-26 Metoda untuk menghasilkan kekebalan aktif dengan vaksin gabungan ID21338A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2708496P 1996-09-30 1996-09-30

Publications (1)

Publication Number Publication Date
ID21338A true ID21338A (id) 1999-05-27

Family

ID=21835595

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW990061A ID21338A (id) 1996-09-30 1997-09-26 Metoda untuk menghasilkan kekebalan aktif dengan vaksin gabungan

Country Status (17)

Country Link
US (2) US6440408B2 (id)
EP (1) EP0951299B1 (id)
JP (1) JP4113588B2 (id)
KR (1) KR100382224B1 (id)
CN (1) CN100389827C (id)
AT (1) ATE272409T1 (id)
AU (1) AU715555B2 (id)
BR (1) BR9713312B1 (id)
CA (1) CA2264810C (id)
CZ (1) CZ94899A3 (id)
DE (1) DE69730152T2 (id)
EA (1) EA199900342A1 (id)
ES (1) ES2224273T3 (id)
ID (1) ID21338A (id)
IL (1) IL128014A (id)
PL (1) PL332540A1 (id)
WO (1) WO1998014212A1 (id)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE200029T1 (de) 1995-06-07 2001-04-15 Pfizer In ovo impfung gegen coccidiose
SK282436B6 (sk) 1995-06-07 2002-02-05 Pfizer Inc. Živé sporocysty alebo oocysty Eimeria alebo ich zmesi na výrobu očkovacej látky
US6969520B2 (en) * 1997-10-20 2005-11-29 Acambis Inc. Active immunization against clostridium difficile disease
US6627205B2 (en) 1997-12-01 2003-09-30 Pfizer Incorporated Ovo vaccination against coccidiosis
DE19828322A1 (de) * 1998-06-25 1999-12-30 Hoechst Roussel Vet Gmbh Coccidienvakzine, Verfahren zu ihrer Herstellung und ihre Verwendung
US6984378B1 (en) 1999-02-26 2006-01-10 Pfizer, Inc. Method for the purification, recovery, and sporulation of cysts and oocysts
DE10007771A1 (de) * 2000-02-14 2001-08-23 Kleine & Steube Entoxin Gmbh Immunmodulatorisch wirksame Zusammensetzungen, Verfahren zu ihrer Herstellung und ihre Verwendung
DK2027873T3 (en) 2001-07-02 2015-11-09 Zoetis Services Llc Single Dose Vaccination with Mycoplasma hyopneumoniae
ATE484573T1 (de) 2001-08-30 2010-10-15 Embrex Inc Verbesserte verfahren zur herstellung von oozysten
DE10209821A1 (de) 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung von Proteinen an ein modifiziertes Polysaccharid
ATE526033T1 (de) * 2002-05-21 2011-10-15 Schering Plough Ltd Verfahren für die kultur von sporozoea sp. in vitro und ihre anwendungen
WO2005014655A2 (en) 2003-08-08 2005-02-17 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkyl starch and a protein
JP4602347B2 (ja) 2003-12-03 2010-12-22 ファイザー・プロダクツ・インク 鳥類におけるカンピロバクターの卵内接種
WO2007126816A2 (en) * 2006-03-30 2007-11-08 Embrex, Inc. Methods and compositions for vaccination of poultry
US8040266B2 (en) 2007-04-17 2011-10-18 Cypress Semiconductor Corporation Programmable sigma-delta analog-to-digital converter
US20080311135A1 (en) * 2007-05-22 2008-12-18 Baylor College Of Medicine Immune complex vaccination as a strategy to enhance immunity in the elderly and other immune compromised populations
WO2010141312A2 (en) * 2009-06-01 2010-12-09 Wake Forest University Health Sciences Flagellin fusion proteins and conjugates comprising pneumococcus antigens and methods of using the same
DK3549949T5 (da) 2011-04-22 2024-09-02 Wyeth Llc Sammensætninger vedrørende et mutant Clostridium-difficile-toksin og fremgangsmåder dertil
BR122016023101B1 (pt) 2012-10-21 2022-03-22 Pfizer Inc Polipeptídeo, composição imunogênica que o compreende, bem como célula recombinante derivada de clostridium difficile
EP2934580B1 (en) * 2012-12-20 2019-09-18 Zaklad Badawczo-Wdrozeniowy Osrodka Salmonella "Immunolab" Sp. z o.o. A polyvalent combined immunising and/or therapeutic preparation for use in bacterial infections or food poisoning, particularly salmonellosis, a method for production of this preparation, its use and a vaccine comprising this preparation
WO2014110092A1 (en) * 2013-01-08 2014-07-17 Humabs Biomed Sa Methods of generating robust passive and active immune responses

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1105136A (en) * 1964-03-25 1968-03-06 Wellcome Found Vaccines comprising living protozoa of the genus theileria
IL74289A (en) * 1985-02-10 1989-02-28 Israel State Vaccine system comprising a live-non-virulent vaccine and an adjuvant
DE3785404T2 (de) * 1986-08-18 1993-07-29 British Tech Group Impfstoffe.
US4935007A (en) * 1986-08-28 1990-06-19 Eli Lilly And Company Anticoccidial method
US5026636A (en) * 1987-11-10 1991-06-25 The University Of Texas Board Of Regents Methods and compositions for production of mycoplasmal adhesins
DE3921255A1 (de) 1989-06-29 1991-01-03 Krebsoege Gmbh Sintermetall Verfahren zur erzeugung eines in einem traegergasstrom foerderbaren fluessigkeitsnebels und vorrichtung zur durchfuehrung des verfahrens
US5397568A (en) 1989-10-02 1995-03-14 Whitfill; Craig E. Method of treating infectious bursal disease virus infections
JP3078013B2 (ja) 1989-10-02 2000-08-21 エンブレックス インコーポレイテッド ワクチン接合体の使用方法、ワクチン調整物および製造品
BR9007702A (pt) 1989-10-02 1992-08-18 Embrex Inc Metodo de tratamento
CH682455A5 (fr) * 1991-07-25 1993-09-30 Serge Liotet Composition vaccinale.
US5378820A (en) * 1992-11-09 1995-01-03 Keeler; Calvin L. Gene encoding cytadhesin protein of mycoplasma gallisepticum and its use
US5641491A (en) * 1993-06-15 1997-06-24 The Penn State Research Foundation Escherichia coli strain 364 and use of said strain as a vaccine
SK282436B6 (sk) * 1995-06-07 2002-02-05 Pfizer Inc. Živé sporocysty alebo oocysty Eimeria alebo ich zmesi na výrobu očkovacej látky
US5951976A (en) * 1996-03-28 1999-09-14 Whitenead Institute For Biomedical Research Opsonin-enhanced cells, and methods of modulating an immune response to an antigen

Also Published As

Publication number Publication date
CA2264810C (en) 2010-07-27
EP0951299A1 (en) 1999-10-27
CZ94899A3 (cs) 1999-09-15
IL128014A0 (en) 1999-11-30
JP2000507608A (ja) 2000-06-20
EP0951299B1 (en) 2004-08-04
IL128014A (en) 2003-11-23
ES2224273T3 (es) 2005-03-01
US20030044414A1 (en) 2003-03-06
CN1231614A (zh) 1999-10-13
AU715555B2 (en) 2000-02-03
AU4595397A (en) 1998-04-24
WO1998014212A1 (en) 1998-04-09
BR9713312B1 (pt) 2009-08-11
KR100382224B1 (ko) 2003-04-26
US6890527B2 (en) 2005-05-10
CA2264810A1 (en) 1998-04-09
US6440408B2 (en) 2002-08-27
JP4113588B2 (ja) 2008-07-09
ATE272409T1 (de) 2004-08-15
DE69730152T2 (de) 2005-11-03
EA199900342A1 (ru) 1999-10-28
KR20000048622A (ko) 2000-07-25
BR9713312A (pt) 2000-02-01
PL332540A1 (en) 1999-09-13
DE69730152D1 (de) 2004-09-09
US20020015706A1 (en) 2002-02-07
CN100389827C (zh) 2008-05-28

Similar Documents

Publication Publication Date Title
ID21338A (id) Metoda untuk menghasilkan kekebalan aktif dengan vaksin gabungan
MY125202A (en) Vaccine
NO950881L (no) Nöytraliserende monoklonale menneske-antistoffer mot respiratorisk syncytialt virus
CY1105389T1 (el) Hpv-e7 ως αγωγη εναντι του ιου θηλωματων ανθρωπου
IL118603A0 (en) Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof
MD970199A (en) Induction of a cytotoxic T-lymphocytic answer The invention relates to the medicine, particularly to the immunology and can be used for treatment of bacterial and parasitic infections, tumors and other diseases. The summary of the invention consists in the induction of a cytotoxic T-lymphocytic answer to human and animals by means of a composition consisting of an antigene and an antigenic formulati
EP0495008A4 (en) Method of treatment
AP2000001886A0 (en) Group B streptococcus antigens.
CA2145397A1 (en) Group b streptococcus type ii and type v polysaccharide-protein conjugate vaccines
DE69527986D1 (de) Antigene arznei zur behandlung oder vorbeugung
DE69928523D1 (de) Verotoxin b untereinheit zur immunisierunug
NO940827D0 (no) Parenteral immunisering mot rotavirus
AU6176596A (en) Compositions exhibiting adp-ribosyltransferase activity and methods for the preparation and use thereof
AU6435596A (en) Pasteurella haemolytica type A-1 bacterin-toxoid vaccine
HUP9902513A2 (hu) Aktív immunitás létrehozására szolgáló vakcinakonjugátumok
RU94033173A (ru) Способ повышения репродуктивной функции мужчин
RU95104722A (ru) Способ получения антител к коринебактериям дифтерии